Oslo, 17 February 2022, Carlos de Sousa, Chief Executive Officer and primary
insider in Ultimovacs ASA, has today bought 1,000 shares in the company at an
average price of NOK 93.66 per share. Following this transaction, Carlos de
Sousa and closely related parties hold 16,056 shares and 416,035 share options
in Ultimovacs ASA.

This information is subject to the disclosure requirements pursuant to the
Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities
Trading Act.